Skip to main content
Clinical Trials/NCT05503173
NCT05503173
Recruiting
Not Applicable

Integrated Telehealth Intervention To Reduce Chronic Pain And Unhealthy Drinking Among People Living With HIV (PLWH)

Boston University1 site in 1 country385 target enrollmentMarch 3, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HIV
Sponsor
Boston University
Enrollment
385
Locations
1
Primary Endpoint
Number of heavy episodic drinking days the past month at 6 months
Status
Recruiting
Last Updated
10 months ago

Overview

Brief Summary

This randomized controlled trial is a between-groups design to compare the Motivational and Cognitive Behavioral Management for Alcohol and Pain (MCBMAP) Intervention to a Brief Advice and Information Control condition.

Two-hundred and fifty participants who have HIV with moderate or greater chronic pain will be randomized for the trial. Recruitment will take place through digital media. A unique feature of this intervention trial is that most of the procedures will be conducted remotely which will minimize barriers of transportation and time for participants. Consent and baseline assessment will be completed remotely. Following baseline assessment, participants will complete two weeks of ecological momentary assessment (EMA) to assess alcohol use, chronic pain, physical function and mechanisms of behavior change for alcohol and pain management. Following the two-week phase, participants will be randomly assigned to either the intervention or control condition and meet the interventionist through videoconferencing. Participants will complete outcome assessment measures at 3- and 6-months post-baseline. Following the 3-month outcome assessment, participants will complete another two weeks of EMA.

Registry
clinicaltrials.gov
Start Date
March 3, 2023
End Date
May 2026
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Able to confirm HIV diagnosis, via visual evidence of antiretroviral (ART) medication bottle or medical record presented to study staff over Zoom.
  • Engaged in unhealthy drinking, defined as:
  • \>7 drinks for women / \> 14 drinks for men per week.
  • OR ≥ 3 drinks for women / ≥4 drinks for men on one occasion in the past month.
  • Experiencing moderate or greater chronic pain (4 or greater on the numerical pain rating scale) for at least 3 months.
  • Own a smart phone.
  • Lives in the USA.
  • Has a US mailing address.

Exclusion Criteria

  • History of bipolar, schizoaffective disorder or schizophrenia per self report.
  • Unstable dose of psychoactive medication for pain or alcohol/substance use \[i.e., if on medication, participant has not been on same dose for least 2 months\]
  • History of withdrawal-related seizures or delirium tremens
  • Current non-pharmacological treatment for alcohol use disorder or chronic pain
  • Acute life-threatening illness that requires treatment or intend to have surgery for a pain-related condition in the next 6-months.
  • Current cancer-related pain
  • Unable to provide one or more individuals for follow-up contact
  • Individual who is unwilling to provide their sex at birth
  • Limited or non-readers

Outcomes

Primary Outcomes

Number of heavy episodic drinking days the past month at 6 months

Time Frame: 6 months

Assessed by the Timeline Follow Back (TLFB-30) which is a is a calendar that allows an assessor to obtain an estimate of an individual's daily drinking habits over a 30-day time period.

Number of alcoholic drinks consumed per week at 6 months

Time Frame: 6 months

Assessed by the Timeline Follow Back (TLFB-30) which is a is a calendar that allows an assessor to obtain an estimate of an individual's daily drinking habits over a 30-day time period.

Rating of pain severity and interference at 6 months

Time Frame: 6 months

Assessed by the PEG Scale Assessing Pain Intensity and Interference (PEG) which is a 3-item scale measuring pain intensity, emotional function, and physical function over the past week.

Secondary Outcomes

  • Rating of pain interference at 6 months(6 months)
  • Rating of pain severity at 6 months(6 months)

Study Sites (1)

Loading locations...

Similar Trials